CSIR-Centre for Cellular & Molecular Biology (CCMB) scientists in collaboration with CSIR-National Chemical Laboratory (NCL) announced on Thursday that they have made progress towards developing a non-toxic bio-drug derived from turmeric through a ‘gene silencing approach’ to treat cancer.
Promising tool
‘RNA interference (RNAi)’ is a gene silencing approach and a promising tool for targeted and focused therapy for chronic diseases like cancer. The lack of safe and effective delivery methods for RNAi molecules is one of the key challenges against using RNAi-based therapy in biological systems.